EyePoint, Inc. Derivative Liability, Current
EyePoint, Inc. (EYPT) had Derivative Liability, Current of $128.00 thousand as of 2011-09-30, per its 10-Q/A filed 2011-11-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2012-09-27
- 2011-09-30: Derivative Liability, Current $128.00K.
- 2011-06-30: Derivative Liability, Current $170.00K.
| Period end | Derivative Liability, Current |
|---|---|
| 2011-09-30 | $128.00K 10-Q/A · filed 2011-11-09 |
| 2011-06-30 | $170.00K 10-K · filed 2012-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |